SDC2 and neoplasm: In this study, we used a bisulfite-pyrosequencing methylation assay on an independent group of CRC patients to confirm the high prevalence of aberrant SDC2 methylation in tumor tissues of CRC patients and precancerous biopsies with various stages compared to those of normal tissues.